Advertisement

Topics

Nexia Biotechnologies Incorporated Company Profile

13:43 EST 23rd November 2017 | BioPortfolio

Nexia Biotechnologies is one of the world's largest producers of authentic recombinant spider silk, and a leading North American animal transgenic company. Nexia manufactures biomaterials and therapeutic proteins in the milk of transgenic dairy goats. This technology combines the large scale, cost-effective dairy infrastructure with recombinant DNA technology to produce rare, complex proteins.

Location

21 111 Lakeshore Road PO Box 183
Sainte Anne-de-Bellevue
Quebec
H9X 3V9
Canada

Contact

Fax: 450 424 7465
Email: hr@nexiabiotech.com


News Articles [91 Associated News Articles listed on BioPortfolio]

DGAP-HV: Elanix Biotechnologies AG: -4-

DJ DGAP-HV: Elanix Biotechnologies AG: Bekanntmachung der Einberufung zur Hauptversammlung am 24.08.2017 in Berlin mit dem Ziel der europaweiten Verbreitung gemäß §121 AktG Dow Jones hat von EQS/D....

DGAP-HV: Elanix Biotechnologies AG: -2-

DJ DGAP-HV: Elanix Biotechnologies AG: Bekanntmachung der Einberufung zur Hauptversammlung am 24.08.2017 in Berlin mit dem Ziel der europaweiten Verbreitung gemäß §121 AktG Dow Jones hat von EQS/D....

DGAP-HV: Elanix Biotechnologies AG: -3-

DJ DGAP-HV: Elanix Biotechnologies AG: Bekanntmachung der Einberufung zur Hauptversammlung am 24.08.2017 in Berlin mit dem Ziel der europaweiten Verbreitung gemäß §121 AktG Dow Jones hat von EQS/D....

DGAP-HV: Elanix Biotechnologies AG: -6-

DJ DGAP-HV: Elanix Biotechnologies AG: Bekanntmachung der Einberufung zur Hauptversammlung am 24.08.2017 in Berlin mit dem Ziel der europaweiten Verbreitung gemäß §121 AktG Dow Jones hat von EQS/D....

DGAP-HV: Elanix Biotechnologies AG: -5-

DJ DGAP-HV: Elanix Biotechnologies AG: Bekanntmachung der Einberufung zur Hauptversammlung am 24.08.2017 in Berlin mit dem Ziel der europaweiten Verbreitung gemäß §121 AktG Dow Jones hat von EQS/D....

Fujifilm Diosynth Biotechnologies opens new UK lab

Fujifilm Diosynth Biotechnologies has opened a $9m process development laboratory in Teeside, UK.

Lion Biotechnologies changes name to Iovance Biotherapeutics

Iovance Biotherapeutics, a biotechnology company developing novel cancer immunotherapies based on tumor-infiltrating lymphocyte (TIL) technology, changed its corporate name from Lion Biotechnologies t...

Adaptive Biotechnologies kündigt Kooperation mit Amgen für den Fortschritt der klinischen Entwicklung des clonoSEQ-Assays bei Multiplem Myelom an

Adaptive Biotechnologies, eines der führenden Unternehmen für die Kombination von Sequenzierung der nächsten Generation (Next-Generation Sequencing, NGS) und durchdachter Bioinformatik für die Pro...

PubMed Articles [13 Associated PubMed Articles listed on BioPortfolio]

Ethical principles for the use of human cellular biotechnologies.

Is De-extinction Special?

I have been involved with the current interest in de-extinction since early 2012, nearly its beginning. I have given a lot of thought to the potential risks and benefits of de-extinction. But only rec...

Overcoming the energetic limitations of syngas fermentation.

The fermentation of synthesis gas (including carbon monoxide, carbon dioxide, and hydrogen) with anaerobic acetogens is an established biotechnological process that has recently been transferred to a ...

'You are inferior!' Revisiting the expressivist argument.

According to the expressivist argument the choice to use biotechnologies to prevent the birth of individuals with specific disabilities is an expression of disvalue for existing people with this disab...

Electricity production and microbial characterization of thermophilic microbial fuel cells.

Thermophilic microbial fuel cell (TMFC) offers many benefits, but the investigations on the diversity of exoelectrogenic bacteria are scarce. In this study, a two-chamber TMFC was constructed using et...

Clinical Trials [0 Results]

None

Companies [140 Associated Companies listed on BioPortfolio]

Nexia Biotechnologies Incorporated

Nexia Biotechnologies is one of the world's largest producers of authentic recombinant spider silk, and a leading North American animal transgenic company. Nexia manufactures biomaterials and therapeu...

Nexia Biotechnologies Inc

Until recently Nexia developed and manufactured complex recombinant proteins in the milk of transgenic goats for medical and industrial applications. The Company's two lead programs were Protexia and ...

RAN Biotechnologies

Based in Beverly, MA, USA, RAN Biotechnologies, Inc., www.ranbiotechnologies.com, provides chemicals specially optimized for microfluidic and biotechnological applications. Partic...

Nexia Holdings, Inc.

Open Therapeutics

Open Therapeutics (http://OpenTherapeutics.org) is a crowdsourcing life science firm that creates and attracts therapeutic biotechnologies and crowdsources them for the global ...

More Information about "Nexia Biotechnologies Incorporated" on BioPortfolio

We have published hundreds of Nexia Biotechnologies Incorporated news stories on BioPortfolio along with dozens of Nexia Biotechnologies Incorporated Clinical Trials and PubMed Articles about Nexia Biotechnologies Incorporated for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Nexia Biotechnologies Incorporated Companies in our database. You can also find out about relevant Nexia Biotechnologies Incorporated Drugs and Medications on this site too.

Quick Search
Advertisement
 

Relevant Topic

Biotechnology
Antibodies Antisense Assays Biochips Bioinformatics Biological Therapy Biomarkers Biomaterials Bioscience Cell Culture Cloning Cytokine Diagnostics Dna Extraction Dna Sequencing Dna Transform...


Corporate Database Quicklinks



Searches Linking to this Company Record